Hydrogen Water Triggers Cancer Cell Death in Leukemia Study
- Authors
- Takaaki Komatsu, Yosinori Katakura, Kiichiro Teruya, Kazumichi Otsubo, Shinkatsu Morisawa, Sanetaka Shirahata
- Journal
- Animal Cell Technology: Basic & Applied Aspects
- Year
- 2003
- DOI
- 10.1007/978-94-017-0726-8_67
- Study Type
- Cell Culture
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- Japan
- Health Condition
- Leukemia
- Body System
- Hematologic
TL;DR
Electrolyzed reduced water (ERW) can slow the growth of human leukemia cells and push them to become a different type of cell, unlike the antioxidant N-acetylcysteine (NAC).
Key Finding
Electrolyzed reduced water caused human leukemia cells to stop growing and differentiate into megakaryocytes through sustained activation of a specific cellular signaling pathway (ERK/MAPK), an effect not seen with conventional antioxidants.
Summary
Researchers tested electrolyzed reduced water (water made by passing electricity through it) on human leukemia cancer cells in a lab dish. The treated cells stopped growing, changed shape, and showed signs of turning into a different type of blood cell (megakaryocytes). Interestingly, when they tested a common antioxidant called NAC on the same cells, it did not produce the same effect, suggesting electrolyzed reduced water works through a different mechanism than simple antioxidants.
Practical Takeaway
This is an early laboratory study in cells only, not in animals or humans, so it cannot yet inform real-world health decisions. While the results are intriguing and suggest electrolyzed reduced water may work differently than expected, much more research—including animal studies and eventually human trials—would be needed before any therapeutic claims could be made.
Abstract
Electrolyzed reduced water (ERW) is known to scavenge reactive oxygen species (ROS) which is related to malignant tumor phenotypes. We attempted to clarify the effect of ERW on tumor phenotypes of K562 human leukemia cells. Treatment of K562 cells with ERW resulted in growth arrest, morphological changes, and expression of CD41, a cell marker of megakaryocyte differentiation. However, the morphology of N-acetylcysteine (NAC)-treated cells was rather similar to that of non-treated control K562 cells. These results suggested that ERW, but not NAC can differentiate K562 cells into megakaryocytes. The induction of megakaryocytes from K562 cells by ERW was preceded by a rapid rise in the activity of MEK (MAP kinase /extra-cellular regulated kinases) that leads to sustained activation of ERK (extra-cellular regulated kinases; MAPK). However, In NAC-treated K562 cells, ERK activation was only transient. The different persistency of ERK activation induced by ERW and NAC might affect the cell fate.